Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus

NCT01406717 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: SPIL1033
DRUG: Placebo

Sponsor

Sun Pharmaceutical Industries Limited